PRKAR1A Protein, Human (HEK293, His)
Based on 1 Customer Validation
PRKAR1A protein is a regulatory subunit of cAMP-dependent protein kinase and is critical for cAMP signaling. Upon activation by cAMP, it releases two catalytic monomers and a regulatory dimer from the inactive holoenzyme. PRKAR1A Protein, Human (HEK293, His) is the recombinant human-derived PRKAR1A protein, expressed by HEK293 , with C-6*His labeled tag.
- Species: Human
- Source: HEK293
-
Storage:Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.
Biological Activity
Description
PRKAR1A protein is a regulatory subunit of cAMP-dependent protein kinase and is critical for cAMP signaling. Upon activation by cAMP, it releases two catalytic monomers and a regulatory dimer from the inactive holoenzyme. PRKAR1A Protein, Human (HEK293, His) is the recombinant human-derived PRKAR1A protein, expressed by HEK293 , with C-6*His labeled tag.
Background
PRKAR1A Protein, a regulatory subunit of cAMP-dependent protein kinases, plays a crucial role in cAMP signaling within cells. The inactive holoenzyme consists of two regulatory chains and two catalytic chains, which are released upon activation by cAMP, resulting in the formation of two active catalytic monomers and a regulatory dimer. PRKAR1A Protein interacts with PRKACA and PRKACB, and this interaction has been shown to influence various cellular processes. Additionally, PRKAR1A Protein engages with RFC2, potentially contributing to cell survival. It also interacts with AKAP4, RARA (in the presence of cAMP or FSH, regulating RARA transcriptional activity), phosphorylated PJA2, CBFA2T3 (By similarity), PRKX (regulating this cAMP-dependent protein kinase), C2orf88/smAKAP (possibly targeting PRKAR1A to the plasma membrane), and AICDA, further highlighting its involvement in diverse molecular interactions and pathways.
Technical Parameters
-
Species Human
-
Source HEK293
-
Tag C-6*His
-
Accession
P10644 (E2-V381)
-
Molecular Construction
-
N-term
-
PRKAR1A (E2-V381)
Accession # P10644 -
6*His
-
C-term
-
-
Protein Length
Full Length
-
Synonyms
PRKAR1A; Carney Complex Type 1; Prev. PRKAR1; CAMP-Dependent Protein Kinase Type I-Alpha Regulatory Chain; Prev. PKR1; CAMP-Dependent Protein Kinase Regulatory Subunit RIalpha; Prev. TSE1; Epididymis Secretory Sperm Binding Protein; Prev. Prkar1alpha; Tis
-
AA Sequence
ESGSTAASEEARSLRECELYVQKHNIQALLKDSIVQLCTARPERPMAFLREYFERLEKEEAKQIQNLQKAGTRTDSREDEISPPPPNPVVKGRRRRGAISAEVYTEEDAASYVRKVIPKDYKTMAALAKAIEKNVLFSHLDDNERSDIFDAMFSVSFIAGETVIQQGDEGDNFYVIDQGETDVYVNNEWATSVGEGGSFGELALIYGTPRAATVKAKTNVKLWGIDRDSYRRILMGSTLRKRKMYEEFLSKVSILESLDKWERLTVADALEPVQFEDGQKIVVQGEPGDEFFIILEGSAAVLQRRSENEEFVEVGRLGPSDYFGEIALLMNRPRAATVVARGPLKCVKLDRPRFERVLGPCSDILKRNIQQYNSFVSLSV
-
Predicted Molecular Mass
44 kDa
-
Molecular Weight
Approximately 45-55 kDa, based on SDS-PAGE under reducing conditions.
-
Purity
≥ 90%, as determined by reducing SDS-PAGE.
Product Properties
Lyophilized powder.
Lyophilized from a 0.2 μm filtered solution of 20 mM PB, 150 mM NaCl, pH 7.4.
<1 EU/μg, determined by LAL method.
It is not recommended to reconstitute to a concentration less than 100 μg/mL in ddH2O. For long term storage it is recommended to add a carrier protein (0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose).
Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.
Room temperature in continental US; may vary elsewhere.
Documentation
-
Data Sheet (238 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)